This Blueprint Medicines Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• Lake Street analyst Frank Takkinen initiated coverage on Axogen, Inc. (NASDAQ:AXGN) with a Buy rating and announced a price target of $30. Axogen shares closed at $17.25 on Friday. See how other analysts view this stock.
• Craig-Hallum analyst John Wilkin initiated coverage on Personalis, Inc. (NASDAQ:PSNL) with a Buy rating and announced a price target of $8. Personalis shares closed at $3.63 on Friday. See how other analysts view this stock.
• William Blair analyst Andrew Brackmann initiated coverage on Butterfly Network, Inc. (NYSE:BFLY) with an Outperform rating. Butterfly Network shares closed at $2.68 on Friday. See how other analysts view this stock.
• Roth MKM analyst Craig Irwin initiated coverage on EZCORP, Inc. (NASDAQ:EZPW) with a Buy rating and announced a price target of $16. EZCORP shares closed at $13.45 on Friday. See how other analysts view this stock.
• Jefferies analyst Michael Yee initiated coverage on Blueprint Medicines Corporation (NASDAQ:BPMC) with a Buy rating and announced a price target of $135. Blueprint Medicines shares closed at $89.58 on Friday. See how other analysts view this stock.

Considering buying BPMC stock? Here’s what analysts think:

• See how other analysts view this stock.

Photo: Bigc Studio/Shutterstock.com